Contact Us اتصل بنا

Company
- Main menu Company
  Meet the faces behind Fresenius Kabi. Learn about our key figures, aspirations, and our role in the ever-changing healthcare landscape.
Portfolio
- Main menu Portfolio
  Discover Fresenius Kabi's portfolio in Pharma, Nutrition, MedTech und Biopharma. Explore our innovative solutions for improved healthcare results.
Responsibility
- Main menu Responsibility
  Learn all about our Corporate Social Responsibility (CSR), our commitment to the UN Sustainable Development Goals (SDG), and our societal impact.
Work With Us
- Main menu Work With Us
  Learn more about the benefits of being a part of Fresenius Kabi. Why we are the right company for you to get ahead in your job and your development.
  - Work With Us Why Us
  - Work With Us Your Opportunities
Products
- Main menu Products
  We Develop, produce and market pharmaceuticals and medical devices for the therapy and care for critically and chronically ill patients worldwide. Our products are vital in the treatment in hospital and outpatient care.

Oxitan (Oxaliplatin)

Oxaliplatin Kabi
5 mg/ml
Concentrate for solution for infusion

Details

Features
Indication
Dosage
Product Info

Oxaliplatin is a platinum-based drug, usually classified as alkylating group.

Oxaliplatin in combination with 5-fluorouracil and folinic acid is indicated for:

Adjuvant treatment of stage III (Duke’s C) colon carcinoma after complete resection of primary tumor
Treatment of metastatic colorectal carcinoma

Strength is denoted by disposable cap color.

RTU (Ready to use) Concentrate:

Oxaliplatin Kabi 50 mg/25ml
Oxaliplatin Kabi 100 mg/50 ml

Registered product information may differ in your country. Before prescribing refer to nationally approved Prescribing Information.